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Objective. Pluripotent mesenchymal stem cells (MSC) have been isolated and well
characterized from several tissue sources, including bone marrow stroma. MSC from different
animals showed slight differences in morphology and in the potential to differentiate. In the
present study, we isolated MSC from bovine bone marrow and induced chondrogenesis in
order to establish a new experimental model of stem cell research.
Methods. Bone marrow was harvested from 8 calves. For inducing chondrogenesis, MSC were
cultured in pellet culture system in a chemically defined medium supplemented with 0 and
10 ng/mL of transforming growth factor b1 (TGF-b1). Chondrogenic differentiation was
evaluated by histological, immunohistochemical, and in situ hybridization techniques. The
degrees of genes expression were measured by quantitative RT-PCR.
Results. Metachromatic alcian blue staining and immunoreactivity for type II collagen were
detected in both pellet groups (0 and 10 ng/mL TGF-b1) after 7 days of culturing. In situ
hybridization demonstrated strong expression of type II collagen and aggrecan mRNAs in the
round cells located at the center region of pellets and at densely organized areas. On the other
hand, type I collagen mRNA was strongly expressed in the superficial layer of the pellets.
After 20 days of pellet culture, expression of type II collagen mRNA in the cells which were
not treated by TGF-b1 was 1.7-fold higher compared with that treated by TGF-b1.
Conclusion. Independent, spontaneous chondrogenesis of bovine MSC in pellet culture
occurred without addition of any external bioactive stimulators, namely factors from TGF-
b family, which were previously considered necessary.  2004 International Society for
Experimental Hematology. Published by Elsevier Inc.Adult stem cells have been isolated and well characterized
from several tissue sources including bone marrow [1], cen-
tral nervous system [2,3], retina [4], skeletal muscles [5],
dermis of mammalian skin [6], and adipose tissue [7]. In
the past three decades, most of the work was focused
on mesenchymal stem cells (MSC) found within the bone
marrow stroma. Bone marrow MSC were purified and ex-
panded and multilinage differentiation was induced in a
number of species including rat [8], rabbit [9], dog [10],
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differentiation, MSC should be cultivated under appropriate
culture conditions and stimulated with some bioactive fac-
tors. Many growth factors, including transforming growth
factor β1 (TGF-β1), bone morphogenic protein (BMP), fi-
broblast growth factor (FGF), and insulin-like growth factor
(IGF-I), have been evaluated for the potential to enhance
chondrogenesis [15].
Defects of the cartilage have been known to be poor
healing injuries, which treated by conventional surgical
methods do not lead to hyaline cartilage regeneration. For
this purpose, transplantation of allogeneic or autologous
pluripotentional or mature-differentiated cells that are ex-
panded ex vivo have been attempted to cure such defects.Experimental Hematology. Published by Elsevier Inc.
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lack of suitable donor sites from where large cartilage sam-
ples could be harvested, and by limited potential of mature
chondrocytes to be expanded in vitro without losing their
phenotype [16]. These disadvantages can be substituted by
application of the bone marrow MSC in repairing articular
cartilage defects. Experimental results, in which rabbit
model was used, have been shown that autologous bone
marrow MSC transplanted into artificial osteochondral
defects were able to differentiate into chondrocytes and
repair the defects with hyaline cartilage [9].
Bone marrow MSC harvested from different species
displayed slight differences in morphology and differentia-
tion potential. The number of MSC found in canine bone
marrow is fourfold higher than in humans. Canine MSC
have a much faster doubling time, but lose the osteogenic
potential after second passage [10]. Furthermore, canine
MCS did not form calcificated nodules during osteogenesis in
vitro, which was observed in human and rat MSC [10].
During osteogenesis induced by dexamethasone, feline bone
marrow MSC did not express alkaline phosphatase (ALP)
[14], or human MSC did not express osteocalcin mRNA [17].
Dexamethasone is a potent inducer of osteocalcin and ALP,
which have been reported to be typical markers of osteogenic
differentiation in other species [10,13,16]. MSC harvested
from commonly used strains of inbred mice displayed varia-
tions in yield, growth, and differentiation [18]. Considering
those and other findings, it could be concluded that differenti-
ation processes and mechanisms that are valid for MSC from
one species are not necessarily valid for others. Besides
species character, bone marrow donor, isolation method, in
vitro cell expansion technique, media formulation, and other
factors also must be considered in experiments with MSC
[19–21].
The majority of research concerning MSC has been done
on rodents or humans. Small experimental animals can
be used to research the principles of stem cell transplanta-
tion therapy, but prior to transferring this technology to
the therapy it is important to introduce it to a large-animal
model, which is biomechanically more relevant to humans
[10,22–24]. Cattle are considered large-animal experimental
models, and as such give numerous advantages for making
progress in clinical application of MSC to human medicine,
especially in musculoskeletal health problems. The bovine
animal model, which we introduced for the first time in
the stem cell research, is a potential donor of relatively large
amounts of bone marrow aspirate, and consequently leads
to sufficient yield of isolated MSC, providing further oppor-
tunity to use it in numerous in vitro and in vivo experiments.
The objective of this study is to evaluate suitable methods
for bovine MSC isolation, in vitro expansion, and chondro-
genic differentiation, and to facilitate further in vitro studies
and in vivo experiments for resurfacing cartilage defects
using the bovine model.Materials and methods
Materials
All reagents and supplements were purchased from Sigma Chemi-
cal Co. (St. Louis, MO, USA) unless otherwise noted.
Harvest and isolation of bovine MSC and chondrocytes
Bone marrow was obtained from tuber coxae, femur, crista tibia,
and proximal end of the humerus of 8 Holstein Friesian calves,
ranging from 2 days to 6 months old. The marrow was drawn
into 25-mL syringes containing 1000 units of heparin following
aseptical preparation of the harvesting fields and infiltration with
local anesthetic.
Bovine MSC were isolated by modification of methods pre-
viously described [15,16,25,26]. Briefly, one volume of bone
marrow sample was mixed with two volumes of phosphate-buffered
saline (PBS), and the mixture was centrifuged at 300g for 10
minutes. The supernatant was discarded, and the pellet was washed
two more times with Dulbecco’s Modified Eagle Medium (DMEM;
GIBCO BRL, Grand Island, NY, USA). After determination of the
cell viability and the number using trypan blue staining, following
lysis of erythrocytes by the addition of 4% acetic acid, 5 × 104/
cm2 nucleated cells were plated in T-75 culture flasks in DMEM
(low glucose) containing: penicillin G 100 U/mL, streptomycin
100 µg/mL, amphotericin B 0.25 µg/mL, HEPES 2.4 mg/mL,
NaHCO3 3.7 mg/mL, and 10% fetal bovine serum (FBS; lot No.
5300C, ICN Biomedicals, Aurora, OH, USA). The cells were incu-
bated at 37C in a humidified atmosphere containing 5% CO2.
After 4 days of culturing, the nonadherent cells were removed by
changing the culture media. Following the initial 4 days, which
were necessary for cells to attach to the flask, medium was changed
every 2 to 3 days. On days 12 to 13, cells were detached (0.25%
trypsin/ 0.1% EDTA) and replated according to the standard cultural
technique at a 1:3 or 1:4 dilution (first passage). When cells
began to reach near confluent stage, they were trypsinized and used
for the preparation of pellets. Cell cultures from each calf were
maintained separately.
Chondrocytes were isolated from the articular cartilage har-
vested from the same calf, from which bone marrow was aspirated.
Briefly, cartilage pieces were digested with 0.1 mg/mL of collagen-
ase (Wako Pure Chemical, Osaka, Japan) in DMEM/10% FBS for
18 hours at 37C with gentle stirring followed by filtering through
a 100-µm nylon mesh. Isolated primary chondrocytes were cultured
in monolayer manner under same conditions as MSC for 20 days
and were used for positive control [27,28].
Pellet culture
Cells from the first passage were resuspended in the serum-free
chemically defined medium consisting of DMEM (high-glucose),
insulin 6.25 µg/mL, transferin 6.25 µg/mL, selenious acid 6.25 µg/
mL, bovine serum albumin 1.25 mg/mL, pyruvate 1 mM, linoleic
acid 5.35 µg/mL, and ascorbate 2-phosphate 50 µg/mL. For prepa-
ration of each pellet, aliquots of 1 × 106 cells in 1 mL of defined
medium were spun down at 500g for 10 minutes in a 15-mL
polypropylene conical tube [29]. Pellets were divided into 2 experi-
mental groups according to the presence of the TGF-β1 (0 and 10
ng/mL) (R&D Systems, Minneapolis, MN, USA) in the medium,
and cultivated at 37C in a humidified atmosphere including 5%
CO2 for 20 days by changing the medium every 2 days.
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Pellets were harvested after 7, 10, and 20 days of culturing, fixed
in 10% buffered formalin for 2 hours, embedded in 2% agarose
for easy manipulation, and kept in 70% ethanol overnight. Samples
were embedded in paraffin and 5-µm sections were cut. Hematoxy-
lin and Eosin (H&E) staining of paraffin sections was done for
evaluation of cell morphology in pellets. Sulfated glicosaminogli-
cans (GAG) were visualized by staining with 0.5% alcian blue for
10 minutes. Collagen type I and II were detected using polyclonal
antibodies (LSL Co., Tokyo, Japan) as previously described [27].
Briefly, after deparaffinization, sections were predigested with tryp-
sin at 37C for 30 minutes to facilitate antibody access, endogenous
peroxidase was quenched by the treatment of 0.3% H2O2 in metha-
nol at room temperature for 30 minutes, and nonspecific antibody
binding was blocked by incubation of sections in a 10% normal
goat serum at 37C for 30 minutes. Rabbit anti-bovine collagen
type I and II diluted 1:500 and 1:1000 respectively in 0.01 M PBS
(pH: 7.4) were applied as a primary antibody at 4C, overnight.
Sections were then incubated with the secondary antibody, swine
anti-rabbit immunoglobulin (DAKO, Glostrup, Denmark), for 60
minutes followed by rabbit PAP kit (DAKO). Collagen type I and
II were visualized by the reactions with 0.05% diaminobenzidine
containing 0.01% H2O2.
In situ hybridization
For in situ hybridization, pellets were embedded in OCT compound
and frozen in liquid nitrogen. Frozen sections (10 µm) were cut
and mounted on silane-coated glass slides. Two kinds of nonover-
lapping 45-mer antisense oligonucleotide probes were synthesized
to detect every mRNA of interest. The following gene sequences
were used: for collagen type I nucleotide residues 2408–2453 and
4108–4153 (Gen Bank AB008683); collagen type II nucleotide
residues 278–323 and 777–822 (Gen Bank X02420); and aggrecan
nucleotide residues 5540–5585 and 6750–6795 (Gen Bank
U76615). In situ hybridization was performed as previously de-
scribed [30]. Briefly, the oligonucleotides were labeled with 35S-
adenosine thiotriphosphate to a specific activity of 0.5 × 109 dpm/
µg DNA, using terminal deoxynucleotidyl transferase. Sections
were fixed with 4% paraformaldehyde in 0.1 M PBS (pH 7.4) for
15 minutes and acetylated with 0.25% acetic anhydride in 0.1 M
triethanolamine-HCl (pH 8.0) for 10 minutes. Hybridization was
performed at 42C overnight by the reaction with labeled oligonu-
cleotide probes at a final radioactivity of 0.5 × 107 cpm/mL in 50%
formamide, which contained 30 mM Tris-HCl (pH 7.4), 0.6 M
NaCl, 1 mM EDTA, 100 mM dithiothreitol, 1× Denhardt’s solution,
0.25% sodium dodecyl sulfate (SDS), 10% dextran sulfate, and
200 µg/mL yeast tRNA. Control hybridization was performed in
the presence of 20-fold excess amount of unlabeled antisense probe.
Slides were washed in 2× SSC containing 0.1% sarkosyl for 30
minutes at room temperature, followed by washing 2 times in 0.1×
SSC/0.1% sarkosyl for 40 minutes at 55C. Slides were dipped
into autoradiographic emulsion (NTB-2, Kodak, Rochester, NY,
USA), exposed at 4C for 4 weeks, and counterstained with hema-
toxylin.
Measurement of mRNA level by quantitative PCR method
Expressions of mRNA for genes of interest in the MSC cultured
in pellet culture for 1 and 20 days, and in MSC and chondrocytes
cultured in monolayer for 20 days, were measured by quantitative
PCR method. Total RNA was isolated using Trizol (Invitrogen,Life Technologies, Carlsbad, CA, USA) following the manufactur-
er’s instruction. After samples were treated by DNase to remove
possible contamination of genomic DNA, first-strand complemen-
tary DNA (cDNA) was synthesized from 1 µg total RNA using
M-MLV reverse transcriptase (Invitrogen) with oligo (dT)20 used
as a primer in a 20-µL reaction mixture. The amount of cDNA
was measured by quantitative PCR method using Smart Cycler
System (Cepheid, Sunnyvale, CA, USA). The PCR reaction was
carried out in a 25-µL final volume, which contained PCR buffer,
3 mM MgCl2, 0.3 mM dNTP mixture, 0.3 µM of each primer, and
Taq polymerase (1.25 units/tube) (Takara Biomedicals, Otsu,
Japan). The primer sequences specific for bovine glyceraldehyde-
3-phosphate dehydrogenase (GAPDH), aggrecan, and collagen
type I and II (Table 1) genes were obtained from Gen Bank and
were synthesized at System Science (Sapporo, Japan). Thermal
cycling was carried out at 95C for 5 seconds, 60C for 15 seconds,
and 75C for 15 seconds. The amount of PCR product was estimated
by measurement of the intensity of fluorescence of SYBR Green
I interacted into the PCR product. The mRNA expression level of
target genes was normalized by dividing with the mRNA level
of GAPDH. Quality of the PCR products was checked by melting
curve analysis and electrophoresis of the PCR product. In addition,
the identity of each PCR product was confirmed by sequence analy-
sis (ABI-PRISM 310 Genetic Analyzer, PE Biosystems, Foster
City, CA, USA).
Results
Cell culture
Spindle bipolar to polygonal fibroblastic cells attached to
the flask were observed after 4 days of culturing, at the first
changing of the medium (Fig. 1A). After 10 to 13 days, the
cell culture reached confluence and, at the places where cells
overlap, exhibited more cuboidal morphology. Cells in the
first or further passages showed uniform monolayer (Fig.
1C) and needed approximately 1 week to reach confluence.
Table 1. Chondrogenic marker genes used in quantitative PCR (Q-PCR)
Product Accession
Gene Primer nucleotide sequence size (bp) number
GAPDH Forward 5′ CCT TCA TTG ACC 127 U85042
TTC ACT ACA TGG TCT A
Reverse 5′ TGG AAG ATG GTG
ATG GCC TTT CCA TTG
Collagen I Forward 5′ TGC TGG CCA 120 AB008683
ACC ATG CCT CT
Reverse 5′ CGA CAT CAT
TGG ATC CTT GCA G
Collagen II Forward 5′ ATC CAT TGC 147 X02420
AAA CCC AAA GG
Reverse 5′ CCA GTT CAG
GTC TCT TAG AG
Aggrecan Forward 5′ CAC TGT TAC 303 U76615
CGC CAC TTC CC
Reverse 5′ GAC ATC GTT
CCA CTC GCC CT
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Figure 1. Morphology of bovine mesenchymal stem cells (MSC) cultured in monolayer manner on day 4 (A) and day 10 (B) in primary culture, and on day 7
(C) in first passage analyzed by phase-contrast microscope. Spindle bipolar to polygonal fibroblastic cells could be noticed after 4 days of culturing. Scale bar
100 µm.In our experiment, cells from the first passage were used
for pellet preparation. After centrifuging, a single compact
pellet was formed within 1 to 2 days of incubation in a
chemically defined medium. Approximately 85% of total
prepared samples formed clearly identifiable pellets, which
were further used in the experiment. The reason for unsuc-
cessful pellet formation of some prepared samples might be
unequal quality of isolated cells from different aspirations.
Large differences of cell yield number and quality of MSC
in aspirates from the same donor at the same time were
previously reported, as some cell lines lose potential for
differentiation with time, even under standard culture condi-
tions [21,31].
Histology and immunohistochemistry
For histological and immunohistochemical evaluation, pel-
lets were harvested after 7, 10, and 20 days of culturing.
Pellets were divided into 2 experimental groups, according to
the presence of TGF-β1 (0 and 10 ng/mL) in the culturingmedium. On examination of paraffin sections stained with
H&E, no notable differences in morphology of both pellet
groups after the same period of culturing (Figs. 2 and 3) were
detected. On day 10, the periphery of the pellet consisted
of elongated cells arranged in a few layers, while the center
region contained plump, rounded cells (Fig. 2E). On day
20, pellets retained the previous structure, except that much
more extracellular matrix was observed surrounding the cells
in the center of the pellets. Metachromatic staining with
alcian blue, indicative for matrix of cartilage, was detected
in all of the groups of pellets on day 7, 10, and 20. Staining
was stronger in the center of the pellets on day 7, but this
difference decreased over time of culturing. On day 7 in
the center of the pellet, there were cells in lacunae with
the appearance of hypertrophic chondrocytes surrounded by
metachromatic stained matrix. This morphological modifi-
cation of the cells was time dependent, and on day 20 all
of the cells in the pellet had chondrogenic appearance, exceptFigure 2. MSC cultured in pellet culture system on day 7 (A–D), on day 10 (E–H), and on day 20 (I–L) without treatment by TGF-β1. Hematoxylin and eosin
staining (H&E) of the pellets (A, E, I); alcian blue staining (B, F, J); immunohistochemical staining for detection of type II collagen (C, G, K) and type I
collagen (D, H, L). Positive metachromatic staining and immunoreactivity for type II collagen was detected on day 7 in the center of the pellet, which increased
towards the surface of the pellet time depending. Stronger expression of type I collagen was detected on the surface and in the periphery layers of the pellet. On
day 10, cells that showed appearance of hypertrophic chondrocytes were clearly identified in the center (white arrow), and elongated cells in the periphery layers
(black arrow) of the pellets. Scale bar 100 µm.
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chemical staining for detection of type II collagen (C) and type I collagen (D). There were no notable differences in histological and immunohistochemical
examinations with pellets which have not been treated by TGF-β1. Scale bar 100 µm.the cells in the superficial layer. Metachromatic staining and
morphology of the cells suggested that a cartilaginous matrix
had been synthesized. To confirm these findings, immunohis-
tochemical analysis for type II collagen was carried out
using mono-specific antibody. Positive immunostained areas
corresponded to the metachromatic stained areas and com-
prised the entire pellets on day 20 (Fig. 2K). Type I collagen
was detected in all of the pellet groups, and its intensity
increased towards the surface of the pellets opposite of the
expression of type II collagen (Fig. 2D, H, L). There were not
any notable differences on immunohistochemical examina-
tion between the pellets treated by TGF-β1 in concentrations
of 1 and 5 ng/mL (data not shown), pellets treated in concen-
trations of 10 ng/mL (Fig. 3), and pellets that were not
treated (Fig. 2) during culturing of 20 days.
In situ hybridization
To verify results obtained from histological and immunohis-
tochemical examination, in situ hybridization on the pel-
lets cultured for 20 days was carried out. Type II collagen
mRNA was strongly expressed in cells at the center of pellets
and in the areas where pellets were densely organized
(Fig. 4A). On the other hand, type I collagen mRNA was
strongly expressed in the cells at the periphery of the
pellets, and in less densely organized areas (Fig. 4B). Ag-
grecan mRNA was expressed throughout entire pellets with
slightly more intensive expression at the centers (Fig. 4C).
There were no notable differences in expression of mRNA
between groups of pellets differing in concentrations of TGF-
β1 (data not shown).
Measurement of mRNA expression
Total RNA was extracted from the MSC in pellet culture
on day 1 and 20, and from MSC and chondrocytes cultured
in monolayer manner for 20 days. There was no expression
of chondrocyte-specific genes in pellets after one day of
culturing or in the MSC from the monolayer culture (Fig.
5). Type II collagen and aggrecan mRNA expression were
detected in pellets cultured for 20 days. In pellets that were not
treated by TGF-β1, type II collagen mRNA was 1.7-fold
higher compared to pellets cultured with TGF-β1 (Fig. 6).
TGF-β1 did not have some influence on aggrecan mRNA
expression in pellet-cultured MSC (Fig. 7). When type II
collagen gene expression of MSC in pellet culture was com-
pared to that of chondrocytes, the MSC exhibited 2.4-foldhigher expression. Opposite of that, aggrecan mRNA expres-
sion in MSC from pellet culture was 3.1-fold lower than the
expression level in the chondrocytes. Expression level of
type I collagen mRNA of MSC in monolayer was 3.6-fold
higher than that in pellet culture. TGF-β1 did not have
some remarkable influence on expression of type I collagen
in pellet culture. During culturing in monolayer manner,
chondrocytes showed a normal shift from collagen type II
to collagen type I gene expression (Fig. 5), but still kept the
chondrogenic phenotype [27,28,32].
Discussion
In the present study, we demonstrated that expanded bovine
MSC undergo chondrogenesis under appropriate culture con-
ditions in a serum-free chemically defined medium. Inde-
pendent, spontaneous chondrogenesis of bovine MSC in
Figure 4. In situ hybridization of the pellet without treatment by TGF-β1 on
day 20 for detection of type II collagen (A, D), type I collagen (B, E), and
aggrecan mRNA(C, F). Type I collagen mRNA was strongly expressed in
the cells on the surface of the pellet or in less densely organized areas (black
arrow). Opposite of that, type II collagen and aggrecan mRNAs were ex-
pressed in the deeper part of the pellets. Scale bar (A, B, C) 50 µm; scale bar
(D, E, F) 200 µm.
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type II collagen (COLL II), aggrecan (AGG), type I collagen (COLL I), and
GAPDH mRNA expression: (1) MSC in pellet culture on day 1; (2) MSC in
pellet culture on day 20; (3) MSC in pellet culture on day 20 treated with
10 ng/mL TGF-β1; (4) MSC in monolayer on day 20; (5) chondrocytes in
monolayer culture on day 20; (6) negative control (without reverse
transcriptase). Type II collagen and aggrecan were not detected in the MSC
cultured in monolayer for 20 days and in pellet culture for 1 day.
pellet culture occurred without addition of any external bio-
active stimulators, namely TGF-β1, which was previously
reported to be necessary [13–15,33]. The presence of met-
achromatic-staining matrix, the chondrocytic appearance of
the cells, and detections of type II collagen and aggrecan
mRNAs and proteins in the pellets showed that the tissue
formed by these marrow-derived cells is cartilage.
Bovine MSC had spindle, bipolar to polygonal fibroblas-
tic shape, and exhibited similar form to MSC isolated from
other species [1,8–16]. On examination by phase contrast
microscope, cell culture appeared to be homogeneous after
the third or fourth changing of the medium, by the removal of
nonadherent cells from hematopoietic lineage. Fluorescence-
activated cell sorting (FACS) analysis of the cells from
the first passage showed homogeneous cell size population,
negative on CD4 (data not shown). Morphology and the fact
that cells were able to undergo adipogenic and osteogenic
differentiation in monolayer culture (data not shown), as
well as chondrogenic differentiation in pellet culture, were
the reasons for classifying them as MSCs [12,16].
Chondrogenesis was proven by the detection of sulfated
GAG and strong immunoreactivity for type II collagen in
Figure 6. Quantitative analysis of type II collagen gene expression of MSC
in pellet culture treated with 0 and 10 ng/mL TGF-β1, and in chondrocytes
cultured in monolayer manner for 20 days. The expression level was normal-
ized for the level of GAPDH mRNA. Expression of type II collagen in pellet
culture without treatment by TGF-β1 was presented to be 100%. Data were
evaluated from 4 independent experiments and shown mean  SD.Figure 7. Quantitativeanalysis of aggrecangeneexpression ofMSCin pellet
culture treated with 0 and 10 ng/mL TGF-β1, and in chondrocytes cultured
in monolayer manner for 20 days. The expression level was normalized for
the level of GAPDH mRNA. Expression of aggrecan in pellet culture without
treatment by TGF-β1 was presented to be 100%.
the center of the pellets after 7 days of culturing. The positive
stained area for chondrocytic markers increased with cultur-
ing time, and almost whole pellets were positively stained
after 20 days culturing. MSC from most of the species un-
dergo chondrogenesis under specific circumstances to satisfy
the following conditions: high cell density, which allows
cell-to-cell interaction analogous to those occurring in pre-
cartilage mesenchymal condensation during limb develop-
ment; and the action of bioactive factors that stimulate
chondrogenesis (e.g., TGF-β, BMP, FGF, IGF-I, and dexa-
methasone) [15]. The condensed condition can be obtained
by pellet culture systems [33], which were sufficient external
stimulants for bovine MSC to undergo chondrogenesis. In
our study for preparations of pellets, we used 4 times larger
numbers of cells [29] compared to previous reports [33–36].
The reason was to obtain pellet volume as large as possible,
so that the cells present in the central region would be under
higher pressure. Also, large pellets provide a larger number of
cells to have better conditions for cell-to-cell interactions.
However, we found that spontaneous chondrogenesis of
bovine MSC did not depend on the initiating cell number
used for pellet preparation (data not shown). Previously
Reyes et al. also used 1 × 106 cells for pellet preparation,
but they had to treat human MSC by TGF-β1 to induce
chondrogenesis [29]. Present in situ hybridization clearly
showed highest expression levels of type II collagen mRNA
at the center region of the pellet where the cell density was
higher, suggesting that condensed condition obtained by the
pellet culture system is important for induction of chondro-
genesis. Conversely, on the surface of the pellets, where
the conditions look similar to monolayer culture, the cells
expressed type I collagen and aggrecan, but no type II colla-
gen (Fig. 4). In vitro monolayer cultivation of chondrocytes
is accompanied by dedifferentiation with expression of colla-
gen type I, which turns to redifferentiation of the same
cells with an increase of collagen type II expression in three-
dimensional cultures [37,38]. The importance of the culture
condition in chondrogenesis, being independent of bioac-
tive stimulators, has also been reported in rabbit periosteal
explants cultured in agarose gels [39].
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self-induced chondrogenesis in bovine MSC. One of them
is the species-specific character of stem cells. MSC have
been isolated and characterized from almost all of the experi-
mental animals and humans, and exhibited some species-
specific characteristics in each. For example, in ovine [40] and
feline [14] MSC, ALP activity could not be detected during
osteogenic differentiation; however, increase of ALP activity
is a typical osteogenic phenotype for human and rat MSC
[17,41]. In cultures of embryonic chick limb bud cells and
rabbit periosteal explants, TGF-β1 induced the formation of
cartilaginous tissue [42,43], whereas rat periosteal cell in
pellet culture failed to undergo chondrogenesis by the treat-
ment of TGF-β1 [44]. MSC derived from almost all species
except rat [44] formed cartilage by the pellet culture in
response to TGF-β1 and dexamethasone. In other animals,
spontaneous chondrogenic differentiation of stem cells
was reported to be only sporadic. Fortier et al. reported
spontaneous chondrogenesis of equine MSC cultured in
monolayer manner in culture medium supplemented with
10% FBS [12]. However, chondrogenesis did not occur in
serum-free medium, which could not eliminate the influence
of bioactive stimulants present in the FBS.
The mechanism of chondrogenesis without any bioactive
stimulants observed in bovine MSC remains unknown and
is the subject of our ongoing research. Most likely, the con-
densed culture condition is the first stimulant for inducing
further autocrine/paracrine cytokine secretion on a cellular
level, which proceeds to complete differentiation to the chon-
drocytes. However, it is not yet reliable to discuss which
cytokine, or what other factors may play a role.
TGF-β1 treatment of bovine MSC in pellet culture de-
creased expression of type II collagen mRNA. The same
effect of TGF-β1 has been reported on freshly isolated chon-
drocytes cultured in monolayer culture [16]. The effects
of TGF-β1 on chondrocyte proliferation and synthesis of
extracellular matrix proteoglycan and type II collagen is
contextual and may be stimulatory or inhibitory, depending
on the stage of cellular differentiation, growth condition,
and the presence of other factors. TGF-β1 reduced matrix
protein expression and inhibited DNA synthesis in freshly
isolated chondrocytes, but stimulated collagen type II and
aggrecan expression in long-term cultured cells [45]. In
monolayer culture, chondrocytes changed their form from
the polygonal one recognized immediately after isolation
to the fibroblastic one observed after one week of culturing.
During these transformations of cell shape, type II TGF-β
receptors changed in size. Type II TGF-β receptors predomi-
nantly expressed in cultured chondrocytes are approximately
15 kDa smaller than those expressed in freshly isolated
chondrocytes, and are postulated to be nonfunctional [45].
Long-term cultured chondrocytes have fibroblastic shapes
similar to MSC expanded in monolayer for two passages, and
both respond to stimulation with TGF-β1 by expression of
type II collagen mRNA (our unpublished data). MSC inpellet culture changed their shape from fibroblastic to polyg-
onal, in which case TGF-β1 actually had a suppressive effect
on expression of type II collagen.
It has been previously reported that age of the donor had
no relationship with the ability of the culture-expanded MSC
to undergo chondrogenesis [46]. Some other stem cells with
chondrogenic potential, derived from a different origin,
such as human periosteum-derived cells from donors
younger than 30 years, undergo focal chondrogenic differen-
tiation in the first or second passage in monolayer culture
[34,47,48]. De Bari looked for a possible explanation for
losing potential for spontaneous chondrogenesis upon pas-
saging in the cell selection, so that periosteum-derived
cells responsible for the formation of chondrogenic nodules
were overgrown by other cell subsets [34]. Physical and
health conditions of the donors might have influence on the
characteristics and potential of the stem cells. For exam-
ple, human MSC isolated from patients with advanced osteo-
arthritis have reduced chondrogenic and adipogenic activities
[46]. Considering these results, we should mention that
bone marrow aspirates in our study were harvested from
young animals (2 days to 6 months old), and could be one
of the reasons for the observed high chondrogenic potential
of the cells. In addition, we confirmed spontaneous chondro-
genesis of bovine MSC isolated from adult donors (more
than 4 years old), but comparing chondrogenic potentional
of MSC harvested from young to that of adult animals was
beyond the scope of our research.
In conclusion, we demonstrated that the species character
must be considered in all experiments involving MSC. We
have shown that the process of chondrogenic differentiation
in bovine MSC appears to be different from other species,
but further experimental work is necessary in order to be well
understood. Finally, we made the first step in establishing a
new animal experimental model for MSC research.
References
1. Haynesworth SE, Baber MA, Caplan AI. Cell surface antigens on
human marrow-derived mesenchymal cells are detected by monoclonal
antibodies. Bone. 1992;13:69–80.
2. Reynolds BA, Weiss S. Generation of neurons and astrocytes from
isolated cells of the adult mammalian central nervous system. Science.
1992;255:1707–1710.
3. Gage FH. Mammalian neural stem cells. Science. 2000;287:1433–1438.
4. Tropepe V, Coles BL, Chiasson BJ, et al. Retinal stem cells in the
adult mammalian eye. Science. 2000;287:2032–2036.
5. Jackson KA, Mi T, Goodell MA. Hematopoietic potential of stem cells
isolated from murine skeletal muscle. Proc Natl Acad Sci U S A. 1999;
96:14482–14486.
6. Toma JG, Akhavan M, Fernandes KJ, et al. Isolation of multipotent
adult stem cells from the dermis of mammalian skin. Nat Cell Biol.
2001;3:778–784.
7. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of
multipotent stem cells. Mol Biol Cell. 2002;13:4279–4295.
8. Dennis JE, Caplan AI. Porous ceramic vehicles for rat-marrow-derived
(Rattus norvegicus) osteogenic cell delivery: effects of pre-treatment
with fibronectin or laminin. J Oral Implantol. 1993;19:106–115.
D. Bosnakovski et al. /Experimental Hematology 32 (2004) 502–509 5099. Wakitani S, Goto T, Pineda SJ, et al. Mesenchymal cell-based repair
of large, full-thickness defects of articular cartilage. J Bone Joint Surg
Am. 1994;76:579–592.
10. Kadiyala S, Young RG, Thiede MA, Bruder SP. Culture expanded
canine mesenchymal stem cells possess osteochondrogenic potential
in vivo and in vitro. Cell Transplant. 1997;6:125–134.
11. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchy-
mal stem cells derived from adult marrow. Nature. 2002;418:41–49.
12. Fortier LA, Nixon AJ, Williams J, Cable CS. Isolation and chondrocytic
differentiation of equine bone marrow–derived mesenchymal stem
cells. Am J Vet Res. 1998;59:1182–1187.
13. Ringe J, Kaps C, Schmitt B, et al. Porcine mesenchymal stem cells.
Induction of distinct mesenchymal cell lineages. Cell Tissue Res. 2002;
307:321–327.
14. Martin DR, Cox NR, Hathcock TL, Niemeyer GP, Baker HJ. Isolation
and characterization of multipotential mesenchymal stem cells from
feline bone marrow. Exp Hematol. 2002;30:879–886.
15. Mastrogiacomo M, Cancedda R, Quarto R. Effect of different growth
factors on the chondrogenic potential of human bone marrow stromal
cells. Osteoarthritis Cartilage. 2001;9(suppl A):S36–40.
16. Worster AA, Nixon AJ, Brower-Toland BD, Williams J. Effect of
transforming growth factor β1 on chondrogenic differentiation of cul-
tured equine mesenchymal stem cells. Am J Vet Res. 2000;61:1003–
1010.
17. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. Osteogenic differen-
tiation of purified, culture-expanded human mesenchymal stem cells
in vitro. J Cell Biochem. 1997;64:295–312.
18. Phinney DG, Kopen G, Isaacson RL, Prockop DJ. Plastic adherent
stromal cells from the bone marrow of commonly used strains of inbred
mice: variations in yield, growth, and differentiation. J Cell Biochem.
1999;72:570–585.
19. Phinney DG, Kopen G, Righter W, Webster S, Tremain N, Prockop
DJ. Donor variation in the growth properties and osteogenic potential
of human marrow stromal cells. J Cell Biochem. 1999;75:424–436.
20. Hung SC, Chen NJ, Hsieh SL, Li H, Ma HL, Lo WH. Isolation and
characterization of size-sieved stem cells from human bone marrow.
Stem Cells. 2002;20:249–258.
21. Sekiya I, Larson BL, Smith JR, Pochampally R, Cui JG, Prockop
DJ. Expansion of human adult stem cells from bone marrow stroma:
conditions that maximize the yields of early progenitors and evaluate
their quality. Stem Cells. 2002;20:530–541.
22. Aerssens J, Boonen S, Lowet G, Dequeker J. Interspecies differences
in bone composition, density, and quality: potential implications for
in vivo bone research. Endocrinology. 1998;139:663–670.
23. Liu Y, Chen F, Liu W, et al. Repairing large porcine full-thickness
defects of articular cartilage using autologous chondrocyte-engineered
cartilage. Tissue Eng. 2002;8:709–721.
24. Kon E, Muraglia A, Corsi A, et al. Autologous bone marrow stromal
cells loaded onto porous hydroxyapatite ceramic accelerate bone repair
in critical-size defects of sheep long bones. J Biomed Mater Res. 2000;
49:328–337.
25. Worster AA, Brower-Toland BD, Fortier LA, Bent SJ, Williams J,
Nixon AJ. Chondrocytic differentiation of mesenchymal stem cells
sequentially exposed to transforming growth factor–β1 in monolayer
and insulin-like growth factor-I in a three-dimensional matrix. J Orthop
Res. 2000;19:738–749.
26. Holzer G, Einhorn TA, Majeska RJ. Estrogen regulation of growth
and alkaline phosphatase expression by cultured human bone marrow
stromal cells. J Orthop Res. 2002;20:281–288.
27. Kim G, Okumura M, Bosnakovski D, et al. Effects of ascorbic acid
on proliferation and biological properties of bovine chondrocytes in
alginate beads. Jpn J Vet Res. 2003;51:83–94.
28. Hering TM, Kollar J, Huynh TD, Varelas JB, Sandell LJ. Modulation
of extracellular matrix gene expression in bovine high-density chondro-
cyte cultures by ascorbic acid and enzymatic resuspension. Arch
Biochem Biophys. 1994;314:90–98.29. Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, Verfaillie CM. Purifi-
cation and ex vivo expansion of postnatal human marrow mesodermal
progenitor cells. Blood. 2001;98:2615–2625.
30. Mowa CN, Iwanaga T. Expression of estrogen receptor-α and -β mRNAs
in the male reproductive system of the rat as revealed by in situ
hybridization. J Mol Endocrinol. 2001;26:165–174.
31. Digirolamo CM, Stokes D, Colter D, Phinney DG, Class R, Pro-
ckop DJ. Propagation and senescence of human marrow stromal cells
in culture: a simple colony-forming assay identifies samples with the
greatest potential to propagate and differentiate. Br J Haematol. 1999;
107:275–281.
32. Kolettas E, Buluwela L, Bayliss MT, Muir HI. Expression of cartilage-
specific molecules is retained on long-term culture of human articular
chondrocytes. J Cell Sci. 1995;108:1991–1999.
33. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. In vitro
chondrogenesis of bone marrow–derived mesenchymal progenitor cells.
Exp Cell Res. 1998;238:265–272.
34. De Bari C, Dell’Accio F, Luyten FP. Human periosteum-derived cells
maintain phenotypic stability and chondrogenic potential throughout
expansion regardless of donor age. Arthritis Rheum. 2001;44:85–95.
35. Izumi T, Scully SP, Heydemann A, Bolander ME. Transforming growth
factor β1 stimulates type II collagen expression in cultured periosteum-
derived cells. J Bone Miner Res. 1992;7:115–121.
36. Murphy JM, Dixon K, Beck S, Fabian D, Feldman A, Barry F. Reduced
chondrogenic and adipogenic activity of mesenchymal stem cells from
patients with advanced osteoarthritis. Arthritis Rheum. 2002;46:704–
713.
37. Lemare F, SteimbergN, LeGriel C,Demignot S,Adolphe M. Dedifferen-
tiated chondrocytes cultured in alginate beads: restoration of the differ-
entiated phenotype and of the metabolic responses to interleukin-1β.
J Cell Physiol. 1998;176:303–313.
38. Schulze-Tanzil G, de Souza P, Villegas Castrejon H, et al. Redifferentia-
tion of dedifferentiated human chondrocytes in high-density cultures.
Cell Tissue Res. 2002;308:371–379.
39. O’Driscoll SW, Recklies AD, Poole AR. Chondrogenesis in periosteal
explants. An organ culture model for in vitro study. J Bone Joint Surg
Am. 1994;76:1042–1051.
40. Kon E, Muraglia A, Corsi A, et al. Autologous bone marrow stromal
cells loaded onto porous hydroxyapatite ceramic accelerate bone repair
in critical-size defects of sheep long bones. J Biomed Mater Res. 2000;
49:328–337.
41. Mizuno M, Fujisawa R, Kuboki Y. Type I collagen-induced osteoblastic
differentiationof bone-marrow cellsmediated bycollagen-α2β1 integrin
interaction. J Cell Physiol. 2000;184:207–213.
42. Roark EF, Greer K. Transforming growth factor -β and bone morphogen-
etic protein-2 act by distinct mechanisms to promote chick limb cartilage
differentiation in vitro. Dev Dyn. 1994;200:103–116.
43. Nishimura K, Solchaga LA, Caplan AI, Yoo JU, Goldberg VM, John-
stone B. Chondroprogenitor cells of synovial tissue. Arthritis Rheum.
1999;42:2631–2637.
44. Hanada K, Solchaga LA, Caplan AI, et al. BMP-2 induction and TGF-
β 1 modulation of rat periosteal cell chondrogenesis. J Cell Biochem.
2001;81:284–294.
45. GlansbeekHL,vander KraanPM,VittersEL, vandenBergWB. Correla-
tion of the size of type II transforming growth factor β (TGF-β) receptor
with TGF-β responses of isolated bovine articular chondrocytes. Ann
Rheum Dis. 1993;52:812–816.
46. Yoo JU, Barthel TS, Nishimura K, et al. The chondrogenic potential of
human bone-marrow-derived mesenchymal progenitor cells. J Bone
Joint Surg Am. 1998;80:1745–1757.
47. NakaharaH,Bruder SP,HaynesworthSE,et al.Boneandcartilageforma-
tion in diffusion chambers by subcultured cells derived from the perios-
teum. Bone. 1990;11:181–188.
48. Nakata K, Nakahara H, Kimura T, et al. Collagen gene expression during
chondrogenesis from chick periosteum-derived cells. FEBS Lett. 1992;
299:278–282.
